E

United Health Products, Inc. UEEC

$0.04 $0.0115.12% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

United Health Products, Inc. operates in the healthcare and biomedical products sector, with a primary focus on hemostatic technologies used to control bleeding in surgical and wound-care settings. The company’s principal product platform is HemoStyp, a patented cellulose-based hemostatic gauze designed to absorb blood and assist in clot formation during medical procedures. The company has historically positioned itself within the broader medical device and surgical products industry, targeting hospitals, surgical centers, emergency care providers, and wound management applications.

The company evolved from earlier business activities into a healthcare-focused enterprise centered on intellectual property and commercialization of hemostatic products. Public disclosures indicate that United Health Products has concentrated much of its corporate strategy on regulatory pathways, patent protection, and commercialization planning associated with HemoStyp technology. Available public filings and disclosures indicate the company remains in a developmental and commercialization-focused stage relative to larger established medical device manufacturers.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Friday, August 14, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

Price History

Loading...
52-Week Range12% of range
Low
$0.03
Current
$0.04
High
$0.12
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
475 755 1005
Address
520 Fellowship Road
Suite D-406
Mount Laurel, NJ 08054
Country
Year Founded

Headlines

There are no news to display.